Pharmaceutical giant Roche has agreed to buy San Diego-based Poseida Therapeutics for about $1 billion in its effort to ...

Patients allegedly exposed to a higher cancer risk from 'defective' breast implants that have now been recalled are suing a ...

The Singapore facility is part of Sanofi's 900 million euro investment to develop two new EVFs globally over five years. The ...

While antiviral drugs to treat HIV had been approved a decade earlier, only five out of 33 million people who carried the ...

The Swiss pharmaceutical company invests in a PTC Therapeutics program to develop treatment for Huntington’s disease.

South Korea's antitrust regulator on Tuesday said it has fined leading drugmaker Celltrion 435 million won ($309,900) for engaging in unfair business practices. The biopharmaceutical giant is accused ...

The 58,000 sq m plant – Sanofi’s second factory in Singapore – will produce vaccines and other biopharmaceutical products ...

The deal suggests Roche sees substantial promise in Poseida’s technology, as the offer is 215% above the biotech’s closing ...

Roche has signed an agreement for the acquisition of Poseida Therapeutics in a deal representing a total value of up to ...